What a 34% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
Lucía Berenguer
Page 10 of 18 of this archive, newest first.
Archive — page 10
356 piecesStorage after reconstitution, and the evidence behind the numbers
Sharps disposal is a legal obligation in most jurisdictions and a safety obligation everywhere. Household waste is not a route.
What a 26% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
What a 9% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
What VendorInvestigate is able to certify about a sealed vial, and what it is not
Every certificate circulating in this market answers a question about molecules. Almost none answers a question about organisms, pyrogens, or the integrity of the seal.
What changed at JEEP in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Turnaround, cost and accreditation across the services this trade relies on
Endotoxin is the more tractable of the two questions, and a kinetic chromogenic determination is neither slow nor exotic. It is simply not on the menu.
What a 42% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Vitamin D, adiposity, and a volume-of-distribution problem
Reduced intake is a plausible mechanism for deficiency. Reduced absorption is not, and the two are conflated in most of the advice.
What changed at SWB in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What an 8% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
What a 15% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
What changed at GGPeps in February, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 30% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
What a 15% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
What a 13% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
What a 40% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
What changed at SSA in February, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What an 11% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
What changed at BCH in February, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.